The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

2012 Canadian Healthcare Share Price Performance – volatile with opportunities

Wayne Schnarr - seriousA group of 96 Canadian healthcare companies, which was assessed for 2012 share price performance is extremely diverse, with market caps ranging from about $1 million to $10 billion, but most less than $100 million.

The 2012 share price performance of the group showed:

  • Median and average share price changes of -11% and +7%, respectively; and
  • Decliners outnumbered gainers by 54 to 42.

In addition, the sector continued to show high volatility, with 46% (44 of 96) of the companies having share price changes of 40% or more. The 19 companies with share price increases of 40% or more are listed below by sector.

Therapeutics:

  • Cipher Pharmaceuticals (291%)
  • Tekmira Pharmaceuticals (223%)
  • iCo Therapeutics (222%)
  • BioSyent (122%)
  • Acasti (87%)
  • YM BioSciences (70%)
  • Lorus Therapeutics (59%)
  • Transition Therapeutics (54%)
  • Microbix Biosystems (46%)

Devices & Diagnostics:

  • TearLab (280%)
  • biOasis Technologies (161%)
  • Novadaq Technologies (76%)
  • Medifocus (50%)
  • Amorfix Life Sciences (41%)

Services Sub-group:

  • Lifebank (191%; acquired)
  • Patheon (161%)
  • Audiotech Healthcare (79%; taken private)
  • Catamaran (63%)

Other Companies Sub-group:

  • Prometic Life Sciences (104%)

 [The data in this post was compiled for the upcoming 2012 Canadian Healthcare Annual Review, co-authored by myself and Ross Marshall, Senior Vice President, The Equicom Group Inc., a wholly-owned subsidiary of TMX Group Inc.]

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 130 other followers